|
This document from E. I. du Pont de Nemours & Company discusses the status of the C-8 program, which involves further animal testing and blood sampling related to the teratogenic potential of C-8 (PFOA), following findings from 3M, and includes updates on risk assessments and studies being conducted at Haskell Laboratory.
|
— |
AR226-1388
|
KJrO8DdzqJQoYjqnzqj5KbBZX |
11 |